First Trust NYSE Arca Biotechnology Index Fund Rating $159.23 -0.31 (-0.19%) As of 02:07 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.66Holdings in FBT have an aggregate rating of Moderate Buy based on 538 analyst ratings issued in the past year covering 30 companies (100.0% of the portfolio).FBT Aggregate Price Target$158.73-0.31% DownsideHigh Prediction$158.73Average Prediction$158.73Low Prediction$158.73Holdings in FBT have an aggregate price target of $158.73 and a range of $158.73 to $158.73 covering 30 companies (100.0% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.56%ACADACADIA Pharmaceuticals$22.83-0.5%3.677 of 5 stars2.69$26.79 17.3%164.27%NBIXNeurocrine Biosciences$126.48-0.7%4.7529 of 5 stars2.86$162.00 28.1%22Positive News4.03%ALNYAlnylam Pharmaceuticals$311.71-0.2%4.078 of 5 stars2.77$319.58 2.5%263.81%EXASExact Sciences$52.63+0.6%4.6895 of 5 stars2.95$70.90 34.7%22Positive News3.74%EXELExelixis$40.11-1.5%4.6309 of 5 stars2.47$39.76 -0.9%19Positive News3.68%INCYIncyte$68.50+0.3%4.4922 of 5 stars2.22$74.53 8.8%183.61%GMABGenmab A/S$21.15-1.9%3.8747 of 5 stars2.69$39.17 85.2%133.57%ALKSAlkermes$29.10-0.8%4.7613 of 5 stars2.83$40.00 37.5%12Positive NewsAnalyst Upgrade3.55%BNTXBioNTech$107.01+2.5%2.6411 of 5 stars2.83$137.86 28.8%18Analyst Revision3.54%UTHRUnited Therapeutics$292.57+0.3%4.9886 of 5 stars2.69$393.08 34.4%13Positive News3.52%BIIBBiogen$127.12+0.5%4.7917 of 5 stars2.38$188.19 48.0%323.48%MTDMettler-Toledo International$1,152.70+0.6%4.2245 of 5 stars2.40$1,302.11 13.0%10Positive News3.48%NTRANatera$171.77+0.5%1.0561 of 5 stars3.00$184.63 7.5%15Positive News3.47%ONCBeOne Medicines$247.39-2.1%2.2787 of 5 stars3.00$319.00 28.9%6Insider TradeGap Down3.42%ILMNIllumina$90.44+0.2%4.878 of 5 stars2.47$126.94 40.4%19Positive News3.32%GILDGilead Sciences$109.09+1.0%4.9765 of 5 stars2.78$110.55 1.3%27Positive NewsInsider Trade3.31%WATWaters$343.06+1.1%4.0902 of 5 stars2.61$390.19 13.7%183.21%RGENRepligen$119.30+1.5%4.6514 of 5 stars2.69$173.25 45.2%133.13%CORTCorcept Therapeutics$70.65-0.8%4.6665 of 5 stars3.00$138.25 95.7%5Positive News3.12%AMGNAmgen$291.64+0.7%4.4695 of 5 stars2.38$309.22 6.0%24Positive News3.11%ARGXargenex$545.61+1.4%4.3705 of 5 stars3.05$709.18 30.0%22Analyst Revision3.10%MRNAModerna$25.83+1.7%4.4689 of 5 stars2.04$46.61 80.5%233.03%BMRNBioMarin Pharmaceutical$55.20-0.1%4.9636 of 5 stars2.74$93.45 69.3%23Positive News3.03%BRKRBruker$38.15-0.7%4.9469 of 5 stars2.40$56.22 47.4%102.85%VRTXVertex Pharmaceuticals$440.68-1.7%4.5804 of 5 stars2.55$513.32 16.5%29Positive NewsAnalyst Forecast2.77%HALOHalozyme Therapeutics$53.00-0.3%4.8689 of 5 stars2.17$61.90 16.8%12Positive News2.71%REGNRegeneron Pharmaceuticals$511.34-0.4%4.853 of 5 stars2.85$836.48 63.6%262.64%VCYTVeracyte$26.33-1.8%3.5319 of 5 stars2.70$40.90 55.3%10Positive News2.50%KRYSKrystal Biotech$132.63+0.4%4.3989 of 5 stars3.00$211.13 59.2%92.39%SRPTSarepta Therapeutics$20.20-2.7%4.5501 of 5 stars2.46$67.64 234.9%26Analyst DowngradeOptions VolumeHigh Trading Volume This page (NYSEARCA:FBT) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.